BIOGEN INC. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOGEN INC. for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 1,510 | 0 | 1,510 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 154 | 0 | 574 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 132 | 0 | 728 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Payment of Exercise | F | 331.76 | 46 | 15,261 | 236 | 282 to 236 (-16.31 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Buy | M | 0.00 | 132 | 0 | 282 | 150 to 282 (+88.00 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 6,030 | 0 | 6,030 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | J | 0.00 | 1,126 | 0 | 4,174 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | M | 0.00 | 960 | 0 | 5,300 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Payment of Exercise | F | 331.76 | 294 | 97,537 | 930 | 1.2 K to 930 (-24.02 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Buy | M | 0.00 | 960 | 0 | 1,224 | 264 to 1.2 K (+363.64 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | A | 0.00 | 11,450 | 0 | 11,450 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 1,972 | 0 | 7,308 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 1,680 | 0 | 9,280 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 331.76 | 504 | 167,207 | 3,871 | 4.4 K to 3.9 K (-11.52 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 1,680 | 0 | 4,375 | 2.7 K to 4.4 K (+62.34 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 7,540 | 0 | 7,540 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 1,240 | 0 | 4,594 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,056 | 0 | 5,834 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 918 | 0 | 1,896 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 974 | 0 | 2,814 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,517 | 0 | 0 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 418 | 138,676 | 4,603 | 5 K to 4.6 K (-8.33 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,056 | 0 | 5,021 | 4 K to 5 K (+26.63 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 286 | 94,883 | 3,965 | 4.3 K to 4 K (-6.73 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 974 | 0 | 4,251 | 3.3 K to 4.3 K (+29.72 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 455 | 150,951 | 3,277 | 3.7 K to 3.3 K (-12.19 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,517 | 0 | 3,732 | 2.2 K to 3.7 K (+68.49 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 420 | 0 | 1,562 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 358 | 0 | 1,982 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | J | 0.00 | 294 | 0 | 608 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 312 | 0 | 902 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 484 | 0 | 0 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 6,780 | 0 | 6,780 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 106 | 35,167 | 2,231 | 2.3 K to 2.2 K (-4.54 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 358 | 0 | 2,337 | 2 K to 2.3 K (+18.09 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 92 | 30,522 | 1,979 | 2.1 K to 2 K (-4.44 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 312 | 0 | 2,071 | 1.8 K to 2.1 K (+17.74 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Payment of Exercise | F | 331.76 | 153 | 50,759 | 1,759 | 1.9 K to 1.8 K (-8.00 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Buy | M | 0.00 | 484 | 0 | 1,912 | 1.4 K to 1.9 K (+33.89 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | J | 0.00 | 2,253 | 0 | 8,348 | |
Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 1,919 | 0 | 10,601 | |
Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 10,550 | 0 | 10,550 | |
Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Payment of Exercise | F | 331.76 | 614 | 203,701 | 3,118 | 3.7 K to 3.1 K (-16.45 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | CAPELLO JEFFREY D | EVP & Chief Financi ... | Buy | M | 0.00 | 1,919 | 0 | 3,732 | 1.8 K to 3.7 K (+105.85 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,803 | 0 | 6,682 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,535 | 0 | 8,485 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 2,697 | 0 | 0 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,633 | 0 | 3,374 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,735 | 0 | 5,007 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | A | 0.00 | 9,650 | 0 | 9,650 | |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 681 | 225,929 | 35,708 | 36.4 K to 35.7 K (-1.87 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,535 | 0 | 36,389 | 34.9 K to 36.4 K (+4.40 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 798 | 264,744 | 34,854 | 35.7 K to 34.9 K (-2.24 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 2,697 | 0 | 35,652 | 33 K to 35.7 K (+8.18 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 331.76 | 756 | 250,811 | 32,955 | 33.7 K to 33 K (-2.24 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,735 | 0 | 33,711 | 32 K to 33.7 K (+5.43 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 37,680 | 0 | 37,680 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 6,762 | 0 | 25,048 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,760 | 0 | 31,810 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,870 | 0 | 12,112 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,234 | 0 | 17,982 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 331.76 | 2,555 | 847,647 | 28,928 | 31.5 K to 28.9 K (-8.12 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,760 | 0 | 31,483 | 25.7 K to 31.5 K (+22.39 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 331.76 | 2,340 | 776,318 | 25,723 | 28.1 K to 25.7 K (-8.34 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 6,234 | 0 | 28,063 | 21.8 K to 28.1 K (+28.56 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | A | 0.00 | 12,060 | 0 | 12,060 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,859 | 0 | 6,888 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,583 | 0 | 8,747 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,340 | 0 | 2,766 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,422 | 0 | 4,106 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 2,211 | 0 | 0 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 703 | 233,227 | 13,806 | 14.5 K to 13.8 K (-4.85 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,583 | 0 | 14,509 | 12.9 K to 14.5 K (+12.25 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 538 | 178,487 | 12,926 | 13.5 K to 12.9 K (-4.00 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,422 | 0 | 13,464 | 12 K to 13.5 K (+11.81 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 331.76 | 660 | 218,962 | 12,042 | 12.7 K to 12 K (-5.20 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 2,211 | 0 | 12,702 | 10.5 K to 12.7 K (+21.08 %) |